Nov. 21-24 _ BMW Australian PGA Championship (Elvis Smylie) Nov. 28-Dec. 1 _ ISPS Handa Australian Open (Ryggs Johnston) Dec. 5-8 _ Nedbank Golf Challenge (Johannes Veerman) Dec. 12-15 _ Alfred Dunhil...
10.20.2025 Dailymail.co.uk and 2 sites
Akero Therapeutics, Inc. (AKRO) Stock Analysis: A Biotech Hopeful with a 4% Upside Potential Madison Wilson October 20, 2025 10: 50 am For investors seeking opportunities in the biotechnology sector, ...
10.20.2025 Directorstalkinterviews.com and 118 sites
With a sticker price that has risen nearly tenfold since 1998, Enbrel, the blockbuster arthritis drug sold by Amgen, has become emblematic of pharmaceutical industry tactics that keep prices high. Che...
10.23.2025 Nytimes.com
The FDA has approved Tezspire (tezepelumab-ekko; Amgen and AstraZeneca) as an add-on maintenance therapy for patients 12 years of age and older with inadequately controlled chronic rhinosinusitis with...
10.20.2025 Tradingview.com and 6 sitesBy Mark Hulbert Slow and steady performers do better over the long term Stocks have become more volatile after they report earnings. Long-term investors can try to exploit this greater volatility, but shorter-term investors will want to favor lower-volatility stocks in the coming months. General Motors (GM) is a good example - the stock jumped 15% after its earnings report on Oct. 21. Netflix (NFLX) shares fell 10% after it missed earnings on Oct. 22. Such outsized reactions to earnings reports ...
10.23.2025 Marketwatch.com and 2 sites
With help from Daniel Lippman Here are your Lobbying Disclosure Act revenue rankings for the third quarter of 2025: TOP FIRMS: Ballard Partners: $25. 1 million (versus $20. 7 million in Q2 2025 and $4...
10.21.2025 Politico.com and 1 sites
With Daniel Lippman THE WIDE RADIUS OF THE TRUMP BUMP: Washington’s influence industry is going gangbusters nine months into Donald Trump ’s second presidency. As PI highlighted yesterday ( and dove d...
10.22.2025 Politico.com
Rory McIlroy has turned down two more tournaments Rory McIlroy has turned down the chance to play in two lucrative tournaments which would have boosted his earnings for the year even further. The Nort...
10.23.2025 mirror.co.uk , express.co.uk
The emphysema market is anticipated to grow steadily, fueled by a range of emerging therapies under development. Leading candidates like SAR447537 (Sanofi), Alvelestat (Mereo BioPharma), BEAM-302 (Bea...
10.20.2025 Prnewswire.com and 19 sites
Q3 2025 revenue: € 49. 6 million +9. 0% in constant currencies Year-on-year revenue growth in constant currencies of +10. 3% for the first 9 months of the year Early signs of improvements in macroeconomic headwinds having impacted revenue growth in r...
10.21.2025 Globenewswire.com and 4 sites